Janice MacLennan, CEO of Nmblr, notes how AI is transforming biopharma R&D and market access, forcing teams to prove value beyond science and redesign work around human strengths.
Janice MacLennan
Advertisement
Janice MacLennan is a senior strategy consultant to Big Pharma and the founder and CEO of Nmblr.
Articles by Janice MacLennan
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Genentech Expands RNAi Pipeline Through Global Licensing Deal
2
AdvanCell Targets GI Cancer With Peptide-Driven Lead-212 Radiotherapy
3
AstraZeneca’s $15 Billion Investment Deepens China R&D and Manufacturing Footprint
4
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
5